Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens

被引:11
|
作者
Abdou, Asmaa Gaber [1 ]
Shabaan, Mohammed [1 ]
Abdallha, Rania [1 ]
Nabil, Nehal [1 ]
机构
[1] Menoufia Univ, Fac Med, Dept Pathol, Gamal Abd Etnaser St 32511, Shebein Elkom, Egypt
来源
CLINICAL PATHOLOGY | 2019年 / 12卷
关键词
PTC; diagnosis; CK19; TROP-2; cytology; immunohistochemistry; CYTOKERATIN; 19; DIFFERENTIAL-DIAGNOSIS; FOLLICULAR VARIANT; GALECTIN-3; HBME-1; UTILITY; IMMUNOHISTOCHEMISTRY; LESIONS; BENIGN; MARKER;
D O I
10.1177/2632010X19863047
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Papillary thyroid carcinoma (PTC) represents the most common primary malignant thyroid tumor and its diagnosis is dependent on the presence of classic nuclear features that are sometimes seen in some non-neoplastic and benign lesions. Several immunohistochemical markers are used individually or in combination to help in differentiation of PTC from mimickers. The aim of the current study was to assess the diagnostic value of TROP-2 and cytokeratin 19 (CK19) expression in differentiating PTC from other mimickers both singly and in combination. The current study was carried out on 77 surgical specimens (56 PTC and 21 non-neoplastic cases) and 12 cytological specimens (4 THY2, 6 THY4, and 2 THY5). TROP-2 was negative in 81% of non-neoplastic surgical specimens and in 100% of THY2 cytological specimens while it was positive in 71.4% of PTC surgical specimens and 100% of THY4/THY5 cytological specimens. Sensitivity and specificity of TROP-2 positive expression for diagnosis of PTC in surgical specimens reached 71% and 81%. respectively, while it reached 100% for both in cytological specimens. Cytokeratin 19 showed positive expression in 85.7% of non-neoplastic surgical specimens and in 92.9% of PTC surgical specimens. Cytokeratin 19 showed negative expression in 75% of Thy2 cases while it was positive in all studied Thy4 and Thy5 cases. Sensitivity and specificity of CK19 total estimated score for diagnosis of PTC in surgical specimens were 78.6% and 66.7%. respectively, while it reached 100% and 75% in cytological specimens. Positive TROP-2 and CK19 expression in PTC were associated with lymph node metastasis. TROP-2 is a specific rather than sensitive marker while CK19 is a sensitive rather than specific marker in differentiating PTC from other mimickers in surgical specimens. The diagnostic validity of both markers was superior in diagnosis of classic PTC compared with follicular variant PTC. TROP-2 is superior to CK19 in diagnosis of PTC in cytological specimens. Both TROP-2 and CK19 could be used preoperatively in adjunct to hematoxylin and eosin for more confident diagnosis of thyroid cytology and along with radiology as predictors of lymph node metastasis.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China
    Song, Qingbin
    Wang, Deguang
    Lou, Yi
    Li, Changsi
    Fang, Changqing
    He, Xiangmin
    Li, Jianhua
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [22] Diagnostic usefulness of HMBE1 and CK19 and evaluation of their expression in follicular-patterned lesions with questionable features of papillary thyroid carcinoma
    Mekni, Amina
    Azouz, Heifa
    Chelly, Ines
    Bellil, Khadija
    Bellil, Selma
    Kchir, Nidhameddine
    Haouet, Slim
    Sahtout, Samia
    Besbes, Ghazi
    Zitouna, Moncef
    VIRCHOWS ARCHIV, 2008, 452 : S70 - S70
  • [23] TROP-2 and CD117 Expression in Oncocytic Lesions of the Thyroid: Exceptional Sensitivity and Mediocre Specificity for Oncocytic Papillary Thyroid Carcinoma
    Hartley, Christopher
    Bonneau, Peter N.
    Hunt, Bryan
    MODERN PATHOLOGY, 2016, 29 : 101A - 101A
  • [24] TROP-2 and CD117 Expression in Oncocytic Lesions of the Thyroid: Exceptional Sensitivity and Mediocre Specificity for Oncocytic Papillary Thyroid Carcinoma
    Hartley, Christopher
    Bonneau, Peter N.
    Hunt, Bryan
    LABORATORY INVESTIGATION, 2016, 96 : 101A - 101A
  • [25] Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region
    Kaliszewski, Krzysztof
    Diakowska, Dorota
    Strutynska-Karpinska, Marta
    Rzeszutko, Marta
    Grzegrzolka, Jedrzej
    Dziegiel, Piotr
    Wojtczak, Beata
    Sutkowski, Krzysztof
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2016, 54 (04) : 193 - 201
  • [26] Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma
    Huang, Lihua
    Wang, Xuming
    Huang, Xuan
    Gui, Huawei
    Li, Yan
    Chen, Qiongxia
    Liu, Dongling
    Liu, Lijiang
    ONCOLOGY LETTERS, 2018, 15 (04) : 4269 - 4277
  • [27] Expressions of D2-40, CK19, galectin-3, VEGF and EGFR in papillary thyroid carcinoma
    Gong, Lei
    Chen, Ping
    Liu, Xianjun
    Han, Ying
    Zhou, Yanping
    Zhang, Weidong
    Li, Hong
    Li, Chuanjia
    Xie, Jiang
    GLAND SURGERY, 2012, 1 (01) : 25 - 32
  • [28] Evaluation of Diagnostic Utility of Immunohistochemistry Markers of TROP-2 and HBME-1 in the Diagnosis of Thyroid Carcinoma
    Zargari, Nooshin
    Mokhtari, Maral
    EUROPEAN THYROID JOURNAL, 2019, 8 (01) : 1 - 6
  • [29] Diagnostic significance of Ki67, CK19, Galectin-3 and HBME-1 expression for papillary thyroid microcarcinoma
    Zhou, Yuan
    Chen, Zhi-heng
    Lu, Bo-hao
    Jiang, Hong-gang
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (09): : 4002 - 4006
  • [30] TROP-2, 5hmC, and IDH1 Expression in Anaplastic Thyroid Carcinoma
    Seok, Jae Yeon
    Astvatsaturyan, Kristine
    Peralta-Venturina, Mariza De
    Lai, Jinping
    Fan, Xuemo
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2021, 29 (04) : 368 - 377